Intracellular calcium signalling and vascular reactivity in bartter’s syndrome

Nephron

Volumn 72, Issue 4, 1996, Pages 570-573

  Calò, Lorenzo ^a   D’angelo, Angela ^a   Cantaro, Salvatore ^a   Rizzolo, Monica ^a   Favaro, Silvana ^a   Antonello, Augusto ^a   Borsatti, Arturo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bartter s syndrome; Calcium signalling; IP3; Vascular reactivity

Indexed keywords

CALCIUM ION; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INOSITOL 1,4,5 TRISPHOSPHATE;

ADULT; ARTICLE; BARTTER SYNDROME; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; SCATCHARD PLOT; SIGNAL TRANSDUCTION;

ADULT; BARTTER SYNDROME; BLOOD VESSELS; CALCIUM; FEMALE; HUMANS; INOSINE TRIPHOSPHATE; KINETICS; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION;

EID: 0029876930     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188941     Document Type: Article

References (17)

1. Bartter FC: Bartter's syndrome: A disorder of vascular reactivity. Hypertension 1981:3(suppl l):69-73.
2. Di Virgilio F. Calô L, Cantaro S. Favaro S. Pic-coli A. Borsatti A: Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Barttcr's syndrome. Clin Sei 1987:72:483-488.
3. + level and action of phorbol myristate acetate. J Clin Invest 1987:79:1226-1233.
4. Zipser RD. Rude RK. Zia PK and Fichman MP: Regulation of urinary prostaglandins in Barterr's syndrome. Am J Med 1979;67:263-267.
5. Delaney VB, Oliver JF. Simms M. Costello J. Bourke E: Barttcr's syndrome: Physiological and pharmacological studies. Q J Med 1981: 198:213-232.
6. Cicdcl CL: Regulation of vascular smooth muscle contraction. Fed Proc 1984;43:2390-2398.
7. Berridge MJ: Inositol trisphosphalc and calcium signalling. Nature 1993:361:315-325.
8. Exton JH: Calcium signalling in cells. Molecular mechanisms. Kidney Int 1987:32(suppl 23): S68-S76.
9. Micheli RH, Kirk CJ: Why is phosphatidylinositol degraded in response to stimulation of certain receptors? Trend Pharmacol Sci 1981:2: 86-90.
10. 2* concentration. Biochem 1985:229: 361-367.
11. Somlyo AV. Bond M. Somlyo AP. Scarpa A: Inositol trisphosphatc induced calcium release and contraction in vascular smooth muscle. Proc Natl Acad Sci USA 1985;82:5231-5235.
12. Stoss JS. Stemerman M, Salzmann E, Brown R: A defect in platelet aggregation in Barttcr’s syndrome. Am.I Med 1980;68:171-180.
13. Smith CD. Cox CC. Snydcrman R: Receptor-coupled activation of phosphoinositide-spe-ciftc phospholipase C by an N protein. Science 1986, 32:97-100.
14. Birnbaumer L, Codina J. Mattera R, Yatany A, Scherer N, Toro MJ, Brown AM: Signal transduction by G protein. Kidney Int 1987; 32(suppl 23):S14-S37.
15. Wcstcnfeldcr C. Kurtzmann NA: Barttcr’s syndrome: A disorder of active sodium and/or passive chloride transport in the thick ascending limb of Henle’s loop. Miner Electrolyte Metab 1981;5:135-143.
16. Garr k R. Ziyadeh FN. Jokasky D. Goldfarb S: Banter's syndrome: A unifying hypothesis. Am J Nephrof 1985:5:379-384.
17. 2+ and protein kinase C. J Biol Chem 1991:266:11559-11566.